A new combined test, accelerated exercise following mild hyperventilation (HV), was examined to determine whether it is effective at detecting a positive response in patients with pharmacologically-induced coronary vasospasm and near normal coronary arteries.
tions, 12) disease activity 13) and the occurrence of sporadic ischemic attacks in many cases, satisfactory results have not been obtained with these non-invasive procedures. 14) Only coronary arterial spasms can be detected by angiography, which is an invasive procedure. Some authors have reported that HV and exercise tests were very useful in patients with variant angina to reproduce ST segment elevation on electrocardiography. [15] [16] [17] [18] [19] [20] However, we have reported that our newlycombined protocol was superior for documenting evidence of ischemia compared to an HV test combined with a cold stress test, in a small number of patients with coronary spastic angina, low disease activity, and near normal coronary arteries. 21 ) Moreover, we have recently reported that the effectiveness of our newly combined test was equivalent to that of an ACh test to diagnose patients with coronary artery spasm. 22) This study sought to clarify the sensitivity and specificity of the newly-combined test in a larger number of patients with pharmacology-induced coronary vasospasm, near normal coronary arteries, and non-variant angina.
PATIENTS AND METHODS
Study patients (Table I) : Fifty-eight consecutive patients who underwent both non-invasive spasm provocation tests and diagnostic coronary angiography at our institution were enrolled in this study. They all had pharmacology-induced coronary vasospasms and no significant organic stenosis (<50%). During this period, we performed 1024 diagnostic coronary angiograms. As a result, 172 consecutive patients with coronary spastic angina were diagnosed by intracoronary administration of pharmacologic agents. From these patients, we excluded 114 patients, 54 with fixed stenosis (≥50%), 23 with spontaneous ST-segment elevation, 15 who were >75 years old, 12 who underwent ergonovine (ER) testing alone, and 10 who did not to participate in this study. As control subjects, 46 patients (20 men and 26 women, mean age: 62±8 years, range: 40 to 72) who had normal or near normal coronary arteries and no provoked spasm by intracoronary administration of ACh, were studied because of chest pain or discomfort at rest and/or during exercise. As shown in Table I , calcium-channel blockers had been administered to 20 control patients before admission, 17 had essential hypertension, 19 were habitual smokers, 15 had hyperlipidemia, and 4 had overt diabetes mellitus. Coronary spasm was defined as total or subtotal occlusion of a coronary artery. Of the 58 study patients, 51 had attacks of chest pain associated with or without ST-segment elevation or depression on electrocardiography and total or subtotal occlusion of the coronary artery following the intracoronary injection of ACh. In 7 patients, the attacks were provoked by the intracoronary administration of ER maleate. We classified these patients into 3 groups according to the symptoms as follows: 30 with rest angina, 10 with effort angina, and 18 with rest and effort angina. Significant coronary artery stenosis was defined as ≥50% luminal narrowing. In all patients, spontaneous ST segment elevation was not determined before the study. Before admission, calcium-channel blockers had been administered to 36 study patients. Twenty-one had essential hypertension, 47 were habitual smokers, 22 had hyperlipidemia, and 6 had overt diabetes mellitus. Nineteen had a single spasm and 39 had multiple spasms. No patient had a history of myocardial infarction, chronic obstructive lung disease, or intermittent claudication. The patients were subdivided into 2 groups: sporadic anginal attack <5/month and ≥5/month. The assessment of attack frequency was performed before administration of the calcium antagonist and/or isosorbide dinitrate.
Written informed consent was obtained from each patient before coronary arteriography and the three stress tests, and the protocol of this study was in agreement with the guidelines of the ethical committees at our respective institutions. Spasm provocation test: As previously reported, [23] [24] [25] coronary arteriography was performed in the fasting state with the Sones technique through the brachial artery from 10:00 AM to 4:00 PM under no medication for at least 24 hours except for nitroglycerin, which was stopped 6 hours before the study. A bipolar electrode catheter was inserted into the right ventricular apex through the femoral or antecubital vein and was connected to a temporary pacemaker set at the rate of 45 beats/min. Provocation of coronary spasm was performed with an intracoronary injection of ACh. ACh was injected in incremental doses of 20-80 µg into the right coronary artery and 20-100 µg into the left coronary artery. When ACh failed to provoke spasm or when administration of ACh was considered to be inappropriate due to possible adverse effects, intracoronary injection of ER was then administered 10 minutes after the last ACh test. ER was slowly injected into the right coronary artery at a total dose of 40 µg/40 mL and into the left coronary artery at a total dose of 64 µg/64 mL. In all patients, coronary arteriography after the administration of 5.0 mg isosorbide dinitrate was performed in multiple projections at the end of the study to estimate atherosclerotic lesions.
The percentage of luminal diameter narrowing of coronary arteries was measured by an automatic edge-contour detection computer analysis system (CARDIO 500, Kontron Instrument, Tokyo). The size of the coronary catheter was used to calibrate the image in millimeters and the measurement was performed in the same projection of coronary angiography at each stage. Focal spasm was defined as a discrete transient vessel narrowing of >99% localized in the major coronary artery. Diffuse spasm was diagnosed when a transient vessel narrowing of >99% compared with the baseline coronary angiography was observed from the proximal to distal segment in the 3 major coronary arteries. The arterial segment of coronary arteries and the percent luminal diameter narrowing were determined according to the classification of an American Heart Association Committee Report.
26)
Noninvasive provocation tests for coronary vasospasm: All medications were discontinued at least 24 hours before the study, except for sublingual nitroglycerin administered to relieve angina, which was stopped at least 6 hours before the procedures. After controlling the 12-lead electrocardiogram and blood pressure, 3 spasm provocation tests were performed from 9:00 AM to 11:00 AM within 3 days. As previously reported, 27) on the first day, the HV test was performed and the treadmill exercise test (TET) was performed using Bruce's protocol 28) on the second day. On the third day, the newly combined test was performed. During the tests, the 12-lead electrocardiogram was continuously monitored on an oscilloscope and blood pressure was measured with a cuff sphygmomanometer at 1-minute intervals. When angina was provoked, sublingual nitroglycerin (0.3 mg) was administered. The 12-lead electrocardiogram was recorded at 1-minute intervals and patients were also observed for 10 minutes after the end of the procedures. The degree of ST-segment depression was measured 80 msec after the J point. The test was considered positive when at least 1 of the following ischemic electrocardiographic changes was demonstrated: (1) ST-segment elevation of more than 0.2 mV in at least 2 related leads during and/or after the procedures ; (2) ST segment depression of more than 0.1 mV as a horizontal or downsloping type, or more than 0.2 mV as a junctional type during and/or after the procedures.
For pH and gas analysis, arterial blood samples were taken before and after HV from 20 patients (10 from the HV test and 10 from the newly combined test), and were measured with an autoanalyzer (AVL, COMPACT 2, Graz, Austria). Data analysis: All data are expressed as the mean±SD. Paired and unpaired t tests were used to compare differences among procedures. The prevalence of ischemia-induced changes and variables were compared among four groups by the ANOVA test. A probability (P) value <0.05 was considered statistically significant.
RESULTS
Comparison of clinical characteristics between vasospastic angina patients and control: Sex distribution was different between the two groups and a history of smoking was observed significantly more often in patients with coronary spastic angina than control patients. However, as shown in Table I , no other differences were found between the two groups. Coronary arteriographic findings and spasm provocation test date: Coronary spasms were observed in 112 vessels, consisting of 51 right coronary arteries, 17 left circumflex arteries, and 44 left anterior descending arteries. As a result, 19 had single vessel spasms, 24 had two vessel spasms, and 15 had triple vessel spasms. The ACh test was performed in all patients and the ER test was conducted in 7 patients. In this study, a positive response to provoked spasms with the ACh test was seen in 88% (51/57) of the patients. Ischemic ECG changes among the three tests: As shown in Table II , the newly combined test was not performed in 2 patients (cases 5 and 7), because they had ST-segment elevation during the HV test on the third day. Of the 58 patients, 9 (cases 1-9, 8 men, 56±8 years) had ischemic ECG changes with the HV test, 15 (cases 1, 5, 7, 8, 10-20, 14 men, 63±7 years) had positive responses to the TET, and 35 (cases 1-37 except 5 and 7, 31 men 64±7 years) had positive results with the newly combined test. The remaining 21 patients (cases 38-58, 18 men, 65±7 years) had negative results, even though triple sequential tests were performed.
In the control subjects, no patients had positive responses in the HV test, TET, or the newly combined test. The specificities of the 3 tests were perfect. As shown in Figure 1, differences regarding the prevalence of risk factors among the four groups (Table  III) . The majority of patients in the HV test-positive group had rest and effort angina, while there were many patients with rest angina in the other 2 study groups. The prevalence of sporadic attacks was significantly lower in the all-negative group (1.0±0.7/month) than in the non-invasive test positive groups (4.1±2.6/month). There were no differences concerning the prevalence of calcium channel blocker administration before admission. ECG changes during the three non-invasive tests: As shown in Table IV , the frequency of ST segment elevation in patients in the HV test positive group was significantly higher than that of the TET positive group (67% vs 7%, P<0.01), while patients in the TET positive group had a significantly higher rate of ST segment depression than those in the HV test positive group (93% vs 33%, P<0.01). Anginal pain was produced more often in the HV test positive group than the TET positive group (100% vs 40%, P<0.01). Fourteen of 35 patients in the newly combined test positive group exhibited ST segment elevation and 21 had anginal pain. Multiple spasms were not diagnosed in any patients using the three tests. There were no differences in the variables between the TET and the newly combined test in any patients in the all negative group. Spasm provocation test: There were no differences in the ACh dose used to provoke spasms, the prevalence of configuration of provoked spasms, mean number of induced spasms, or distribution of provoked spasms (Table IV) . The intracoronary administration of ER was performed in 3 patients in the TET positive group, 4 in the newly-combined test positive group, and 3 in the all negative group. Intracoronary administration of ACh was not performed in one patient due to hypoplasty of the right coronary artery. Arterial blood pH and gases before and after hyperventilation: Arterial blood pH increased from 7.42 to 7.63, arterial blood Po 2 increased from 86 mmHg to 119 mmHg, and arterial blood Pco 2 decreased from 39 mmHg to 20 mmHg. plications were encountered during the 3 procedures. Moreover, neither serious arrhythmia such as ventricular tachycardia or fibrillation and second or third atrioventricular block nor hypotension/shock were observed in this study.
DISCUSSION
In vasospastic angina with normal coronary arteries and non-variant angina, satisfactory results may not be obtained using a single procedure non-invasively.
14) Therefore, we combined a modified TET with mild HV in order to detect a higher number of positive responses. We selected mild HV, rather than vigorous HV that causes near syncope, because the patients may have been able to maintain the condition and perform the modified accelerated TET following the HV test. In this study, we attempted to clarify the sensitivity and specificity of the newly-combined test and to determine the clinical characteristics of the newly-combined test positive group in a larger patient population with pharmacology-induced coronary vasospasm, almost normal coronary arteries, and nonvariant angina.
Comparison with previous data and the newly-combined test: In the majority of previous reports, [29] [30] [31] [32] subjects with variant angina who also had significant organic stenosis and reproducible ST segment elevations have been considered as a gold standard. Moreover, there have been only a few reports in which the disease activity and frequency of attacks were described in detail. In these reports, a positive response was revealed by exercise tests in 20-38% of patients with <70% fixed stenosis with coronary spasm, but the disease activity of there patients was unknown. Despite a quiescent phase of the disease (sporadic anginal attacks <5/ week), a positive response was obtained in 63% of our patients using the newly combined test. Compared with the other 3 groups, patients in the all negative group had significantly fewer sporadic attacks. There were no differences concerning the dose of ACh used for the induction of coronary artery spasm among the 4 groups. The diagnostic value of the non-invasive test appears to be limited to patients with low disease activity and no significant stenosis. Moreover, no clinical differences were observed among the 3 groups; the newly combined test positive group, HV test positive group, and TET positive group. Sensitivity and specificity of the newly-combined test : We have already reported that in patients with coronary spastic angina and significant organic stenosis, the sensitivities of the HV test, the TET, and the newly combined test were 15%, 40%, and 84%, respectively. 27) In patients without fixed stenosis (<50%) and coronary spastic angina, the sensitivity of the newly combined test was also significantly higher than that of the HV test or the TET alone (63% vs 16%, 26%, P<0.01), as shown in Figure 1 . The newly combined test was clinically useful for detecting ischemic changes in vasospastic angina with either significant organic stenosis or near normal coronary arteries. The specificity of the newly combined test was perfect. Clinical implications: The newly-combined method is reliable and clinically useful for the induction of ischemic changes in patients with pharmacologyinduced coronary vasospasm, non-variant angina, and no significant stenosis. Thus, two thirds of these patients had a positive response when the newly combined test was porformed as a non-invasive spasm provocation test. This newly combined test has fewer safety problems because no serious or irreversible complications were observed in this study. This method may be more useful for monitoring the changes in coronary spasmodicity and for evaluating the efficacy of drugs than other classic methods alone.
